The treatment doses of 8OH-DPAT35 (link), L-368,89936 (link),37 (link) and OXT30 (link) were determined based on previous reports. The treatment duration of each drug was determined based on our previous reports5 (link). After weaning at PD21, the mice were divided into groups of two to five mice per cage. Saline was used as a control.
Early-life Pharmacological Modulation of the Serotonergic and Oxytocinergic Systems
The treatment doses of 8OH-DPAT35 (link), L-368,89936 (link),37 (link) and OXT30 (link) were determined based on previous reports. The treatment duration of each drug was determined based on our previous reports5 (link). After weaning at PD21, the mice were divided into groups of two to five mice per cage. Saline was used as a control.
Corresponding Organization :
Other organizations : Nippon Medical School, RIKEN Center for Brain Science, Japan Science and Technology Agency
Variable analysis
- 8OH-DPAT (0.5 mg/kg)
- L-368,899 (3 mg/kg)
- OXT (83 I.U. [0.2–0.26 mg]/kg)
- Not explicitly mentioned
- Saline (control)
- Saline (negative control)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!